The growing use of weight-loss drugs like Ozempic could be having an impact on supermarkets’ bottom lines as Brits shy away ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

The growing use of weight-loss drugs like Ozempic could be having an impact on supermarkets’ bottom lines as Brits shy away ...

The growing use of weight-loss drugs like Ozempic could be having an impact on supermarkets’ bottom lines as Brits shy away ...

A $10.2 million savings across more than 100,000 prescriptions over three months, extrapolated across the nearly 33 million Americans currently taking GLP-1 medications monthly, indicates a potential ...

FAT jabs are shrinking supermarket sales, with grocery volumes falling 0.4% year-on-year, new figures reveal. Popular Ozempic ...

Trial finds weight loss drug taken monthly helps people lose 20% of body weight – but adverse GI events were ‘common’ - The ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Mounjaro has been approved for both type 2 diabetes and weight loss, but access will be limited by strict eligibility ...

While most side effects are likely to disappear when the medication is stopped, any damage to the teeth is permanent ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

Weaver outlined her concerns with counterfeit weight-loss medication. “If there is, contaminants, allergens in it, that sort ...